SCHEMBL798577

SCHEMBL798577

Nc1nc(N)c(N)c(N2CCN(F)CC2C(=O)Cc2cccs2)n1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.34
SIGMAR1 Q99720 1/20 0.34
HTR6 P50406 1/20 0.33
ALDH1A1 P00352 3/20 0.32
HSD17B10 Q99714 2/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
CASP1 P29466 1/20 0.32
HTT P42858 1/20 0.32
SHMT2 P34897 1/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
NEK2 P51955 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL654348 0.83 HTR2A (0.35) SIGMAR1HTR6ALDH1A1HSD17B10MAPT
SCHEMBL1695160 0.82 SHMT2 (0.37) TP53SIGMAR1HTR6ALDH1A1HSD17B10
SCHEMBL798809 0.71 GAA (0.39) ALDH1A1GAAMAPTKDM4ELMNA
SCHEMBL798970 0.69 DHFR (0.42) TP53ALDH1A1KDM4ELMNAHPGD
SCHEMBL654025 0.65 HTR2A (0.35) SIGMAR1HTR6ALDH1A1HSD17B10MAPT
Cyclohexane SCHEMBL28743392 0.57 HPGD (0.61) SIGMAR1ALDH1A1HSD17B10MAPTKDM4E
Cyclohexane SCHEMBL27520153 0.57 HPGD (0.61) SIGMAR1ALDH1A1HSD17B10MAPTKDM4E
Cyclopentane SCHEMBL27521437 0.57 HPGD (0.61) SIGMAR1ALDH1A1HSD17B10MAPTKDM4E
Cyclopentane SCHEMBL27521514 0.57 HPGD (0.61) SIGMAR1ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL4775990 0.57 POLB (0.55) ALDH1A1KDM4EHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616077-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-07-24 EP disclosed
EP-2575969-A1 ANTIVIRAL ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-04-10 EP disclosed
WO-2012035423-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-03-22 WO disclosed
WO-2011147753-A1 ANTIVIRAL ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2011-12-01 WO disclosed